BioSpace News Archive

Business

Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies

Will Capitalize on Rapid Internationalization of Clinical Trials Between the US and China

June 24, 2019
·
3 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering of Common Stock - June 24, 2019

Mirati Therapeutics, Inc. announced that it has commenced an underwritten public offering of shares of its common stock.

June 24, 2019
·
4 min read
Pharm Country

Consumer Energy Alliance Launches New Campaign and Report amid Latest Energy Mandate Announcements

Following recent energy policy developments, CEA to provide awareness around potential consequences to families and businesses

June 24, 2019
·
4 min read
Business

Five Prime Therapeutics Appoints Lori Lyons-Williams to its Board of Directors

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced the appointment of Lori Lyons-Williams to its Board of Directors.

June 24, 2019
·
3 min read
BioMidwest

Second-annual Walk for Amazing raises $320,000 to support Children’s Minnesota programs

Nearly two thousand participants from across the Twin Cities metro came out Saturday for the second-annual Walk for Amazing, a celebratory fundraising event supporting the many specialty areas at Children’s Minnesota.

June 24, 2019
·
2 min read
FDA

Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline® Depot (lanreotide)

Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a new pre-filled syringe for Somatuline® Depot (lanreotide).

June 24, 2019
·
13 min read
Genetown

Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the launch of a proposed follow-on public offering of approximately $30.0 million of its ordinary shares.

June 24, 2019
·
3 min read
Genetown

Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Top-Line Results from the SOLACE Trial in Noninfectious Anterior Uveitis

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced it will hold a webcast and conference call on Tuesday, June 25, 2019 at 8:00 a.m.

June 24, 2019
·
1 min read
Deals

ArQule Announces Commencement of Proposed Public Offering of Common Stock - June 24, 2019

ArQule, Inc. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock.

June 24, 2019
·
4 min read
Business

RESTON HOSPITAL CENTER NURSE HONORED WITH HCA EXCELLENCE IN NURSING AWARD

The award recognizes exceptional nursing knowledge and expert skills, consistently applied with compassion and integrity.

June 24, 2019
·
2 min read